Nilo Therapeutics News and Activities

Acquisition, funding and merger involving Nilo Therapeutics.

• Nilo Therapeutics has just announced a $101 Million fundraising (posted on October 9 2025).

View the org chart displaying its 5 main executives

Most searched biographies at Nilo Therapeutics

• Kim Seth, Chief Executive Officer
• Hidenori Takahashi, Vice President, Head of Pharmaceutical Sciences
• Laurens Kruidenier, Chief Scientific Officer

Popular executive movements at Nilo Therapeutics

• Kim Seth has joined the company as Chief Executive Officer  (posted on October 9 2025).
• Hidenori Takahashi has joined the company as Vice President, Head of Pharmaceutical Sciences  (posted on October 9 2025).

Create your alert
to follow the executive moves at Nilo Therapeutics.

Nilo Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Nilo Therapeutics

Social media about Nilo Therapeutics

• Nilo Therapeutics on Wikipedia, Google News & Yahoo Finance
• Nilo Therapeutics on LinkedIn, X (Twitter) & YouTube